Aliases & Classifications for Fg Syndrome 5

MalaCards integrated aliases for Fg Syndrome 5:

Name: Fg Syndrome 5 54 29 13 69

External Ids:

OMIM 54 300581

Summaries for Fg Syndrome 5

MalaCards based summary : Fg Syndrome 5 and has symptoms including constipation An important gene associated with Fg Syndrome 5 is FGS5 (FG Syndrome 5). The drugs Enalapril and Enalaprilat have been mentioned in the context of this disorder. Affiliated tissues include ovary.

Description from OMIM: 300581

Related Diseases for Fg Syndrome 5

Symptoms & Phenotypes for Fg Syndrome 5

Clinical features from OMIM:

300581

UMLS symptoms related to Fg Syndrome 5:


constipation

Drugs & Therapeutics for Fg Syndrome 5

Drugs for Fg Syndrome 5 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 18)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Enalapril Approved, Vet_approved Phase 4 75847-73-3 5362032 40466924
2
Enalaprilat Approved Phase 4 76420-72-9 6917719
3
Losartan Approved Phase 4 114798-26-4 3961
4
Angiotensin II Investigational Phase 4 68521-88-0, 4474-91-3, 11128-99-7 172198 65143
5 Angiotensin II Type 1 Receptor Blockers Phase 4
6 Angiotensin Receptor Antagonists Phase 4
7 Angiotensin-Converting Enzyme Inhibitors Phase 4
8 Angiotensinogen Phase 4
9 Anti-Arrhythmia Agents Phase 4
10 Antihypertensive Agents Phase 4
11 HIV Protease Inhibitors Phase 4
12
protease inhibitors Phase 4
13
Lenalidomide Approved Phase 2 191732-72-6 216326
14 Angiogenesis Inhibitors Phase 2
15 Angiogenesis Modulating Agents Phase 2
16 Anti-Bacterial Agents Phase 2
17 Anti-Infective Agents Phase 2
18 Immunosuppressive Agents Phase 2

Interventional clinical trials:


id Name Status NCT ID Phase Drugs
1 Prevention of Diabetes and Hypertension Terminated NCT00456963 Phase 4 enalapril tablets;placebo tablets;Losartan Tablets
2 Efficacy and Safety of FG-4592 for Treatment of Anemia in Patients With Lower Risk MDS With Low Red Blood Cell Transfusion Burden Recruiting NCT03263091 Phase 3 FG-4592;Placebo
3 Efficacy and Safety of FG-4592 for Treatment of Anemia in Subjects With Lower Risk MDS Not yet recruiting NCT03303066 Phase 2, Phase 3 FG-4592;Placebo
4 JET-GBS - Japanese Eculizumab Trial for GBS Completed NCT02493725 Phase 2 Eculizumab;Placebo
5 Efficacy of Eltrombopag Plus Lenalidomide Combination Therapy in Patients With IPSS Low and Intermediate-risk Myelodysplastic Syndrome With Isolated del5q Recruiting NCT02928419 Phase 2 Eltrombopag/Revolade;Lenalidomide
6 Electroacupuncture on Hormonal and Glycometabolic Profiles in Women With Polycystic Ovary Syndrome: Study Protocol Not yet recruiting NCT02653911

Search NIH Clinical Center for Fg Syndrome 5

Genetic Tests for Fg Syndrome 5

Genetic tests related to Fg Syndrome 5:

id Genetic test Affiliating Genes
1 Fg Syndrome 5 29

Anatomical Context for Fg Syndrome 5

MalaCards organs/tissues related to Fg Syndrome 5:

39
Ovary

Publications for Fg Syndrome 5

Variations for Fg Syndrome 5

Expression for Fg Syndrome 5

Search GEO for disease gene expression data for Fg Syndrome 5.

Pathways for Fg Syndrome 5

GO Terms for Fg Syndrome 5

Sources for Fg Syndrome 5

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....